Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib

Conditions:   NSCLC;   BRAF V600E Mutation;   Advanced Cancer;   Stage IIIB NSCLC;   Stage IV NSCLC Intervention:   Drug: Combind asprin with Trametinib and Dabrafenib Sponsor:   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials